223 related articles for article (PubMed ID: 25808736)
1. Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration.
Thierry S; Munir S; Thierry E; Subra F; Leh H; Zamborlini A; Saenz D; Levy DN; Lesbats P; Saïb A; Parissi V; Poeschla E; Deprez E; Delelis O
Retrovirology; 2015 Mar; 12():24. PubMed ID: 25808736
[TBL] [Abstract][Full Text] [Related]
2. Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase.
Richetta C; Thierry S; Thierry E; Lesbats P; Lapaillerie D; Munir S; Subra F; Leh H; Deprez E; Parissi V; Delelis O
J Biol Chem; 2019 May; 294(20):8286-8295. PubMed ID: 30971426
[TBL] [Abstract][Full Text] [Related]
3. Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors.
Surdo M; Cortese MF; Orlandi C; Di Santo F; Aquaro S; Magnani M; Perno CF; Casabianca A; Ceccherini-Silberstein F
Antiviral Res; 2018 Dec; 160():165-174. PubMed ID: 30420339
[TBL] [Abstract][Full Text] [Related]
4. Reversal of Epigenetic Silencing Allows Robust HIV-1 Replication in the Absence of Integrase Function.
Irwan ID; Karnowski HL; Bogerd HP; Tsai K; Cullen BR
mBio; 2020 Jun; 11(3):. PubMed ID: 32487757
[TBL] [Abstract][Full Text] [Related]
5. Quantitative PCR used to assess HIV-1 integration and 2-LTR circle formation in human macrophages, peripheral blood lymphocytes and a CD4+ cell line.
Friedrich B; Li G; Dziuba N; Ferguson MR
Virol J; 2010 Dec; 7():354. PubMed ID: 21129188
[TBL] [Abstract][Full Text] [Related]
6. The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration.
Mesplède T; Leng J; Pham HT; Liang J; Quan Y; Han Y; Wainberg MA
mBio; 2017 Apr; 8(2):. PubMed ID: 28377526
[TBL] [Abstract][Full Text] [Related]
7. Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex.
Ding J; Zhao J; Yang Z; Ma L; Mi Z; Wu Y; Guo J; Zhou J; Li X; Guo Y; Peng Z; Wei T; Yu H; Zhang L; Ge M; Cen S
Viruses; 2017 May; 9(5):. PubMed ID: 28489061
[TBL] [Abstract][Full Text] [Related]
8. Interaction of HIV-1 integrase with polypyrimidine tract binding protein and associated splicing factor (PSF) and its impact on HIV-1 replication.
Yadav P; Sur S; Desai D; Kulkarni S; Sharma V; Tandon V
Retrovirology; 2019 Apr; 16(1):12. PubMed ID: 31036027
[TBL] [Abstract][Full Text] [Related]
9. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.
Martinez-Picado J; Zurakowski R; Buzón MJ; Stevenson M
Retrovirology; 2018 Jan; 15(1):15. PubMed ID: 29378611
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
Richetta C; Subra F; Malet I; Leh H; Charpentier C; Corona A; Collin G; Descamps D; Deprez E; Parissi V; Calvez V; Tramontano E; Marcelin AG; Delelis O
J Virol; 2022 Jul; 96(14):e0067622. PubMed ID: 35758669
[TBL] [Abstract][Full Text] [Related]
11. Nucleoprotein complex intermediates in HIV-1 integration.
Li M; Craigie R
Methods; 2009 Apr; 47(4):237-42. PubMed ID: 19232539
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD
Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997
[TBL] [Abstract][Full Text] [Related]
13. A quantitative assay for HIV DNA integration in vivo.
Butler SL; Hansen MS; Bushman FD
Nat Med; 2001 May; 7(5):631-4. PubMed ID: 11329067
[TBL] [Abstract][Full Text] [Related]
14. Integrase and integration: biochemical activities of HIV-1 integrase.
Delelis O; Carayon K; Saïb A; Deprez E; Mouscadet JF
Retrovirology; 2008 Dec; 5():114. PubMed ID: 19091057
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA.
Poon B; Chen IS
J Virol; 2003 Apr; 77(7):3962-72. PubMed ID: 12634356
[TBL] [Abstract][Full Text] [Related]
16. Activity of recombinant HIV-1 integrase on mini-HIV DNA.
Cherepanov P; Surratt D; Toelen J; Pluymers W; Griffith J; De Clercq E; Debyser Z
Nucleic Acids Res; 1999 May; 27(10):2202-10. PubMed ID: 10219094
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
[TBL] [Abstract][Full Text] [Related]
18. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.
Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
PLoS One; 2009; 4(1):e4155. PubMed ID: 19127291
[TBL] [Abstract][Full Text] [Related]
19. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions.
Svarovskaia ES; Barr R; Zhang X; Pais GC; Marchand C; Pommier Y; Burke TR; Pathak VK
J Virol; 2004 Apr; 78(7):3210-22. PubMed ID: 15016842
[TBL] [Abstract][Full Text] [Related]
20. Biochemical screening assays to identify HIV-1 integrase inhibitors.
Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O
Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
